Ceapro Inc (CZO):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Ceapro Inc (CZO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10028
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ceapro Inc (Ceapro) is a biotechnology company which develops proprietary extraction technologies for use in the production of extracts and active ingredients from oats and other renewable plant resources. The company’s extracts are also used in nutraceutical, cosmeceutical, and therapeutics products for humans and animals. Ceapro’s portfolio includes natural active ingredients comprising oat avenanthramides, oat oil, oat peptides, oat beta glucan, and lupin peptides; and veterinary products including oat shampoo, ear cleanser and dermal complex/conditioner. The company offers its products in Canada, United States, Germany, China and other countries. Ceapro is headquartered in Edmonton, Alberta, Canada.

Ceapro Inc (CZO) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Ceapro Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ceapro Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Ceapro Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ceapro Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Ceapro Inc, Medical Devices Deals, 2012 to YTD 2018 9
Ceapro Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Ceapro Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Ceapro Enters into Agreement with Montreal Heart Institute 11
Licensing Agreements 12
Ceapro Expands Licensing Agreement with University of Alberta 12
Symrise Enters Into Licensing Agreement With Ceapro 13
Equity Offering 14
Ceapro Raises USD3.3 Million in Second and Final Tranche of Private Placement of Units 14
Ceapro Raises USD4.4 Million in First Tranche of Brokered Private Placement of Units 16
Debt Offering 18
Ceapro Raises USD0.24 Million in Second Tranche of Private Placement of Debentures Due 2016 18
Ceapro Inc – Key Competitors 19
Ceapro Inc – Key Employees 20
Ceapro Inc – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Financial Announcements 22
Aug 28, 2018: Ceapro reports 2018 second quarter and six-month financial results and operational highlights 22
May 17, 2018: Ceapro Announces 2018 First Quarter Results 23
Apr 20, 2018: Ceapro Reports 2017 Financial Results 24
Nov 15, 2017: Ceapro Reports 2017 Third Quarter Business Update and Financial Results 25
Aug 18, 2017: Ceapro Reports 2017 Second Quarter Business Update and Financial Results 27
May 17, 2017: Ceapro Reports 2017 First Quarter Development Highlights and Financial Results 29
Apr 06, 2017: Ceapro Reports 2016 Financial Results and Provides Corporate Update 31
Legal and Regulatory 33
Aug 27, 2018: Ceapro settles judgements in AVAC actions 33
Product News 34
May 29, 2018: Ceapro Confirms Excellent Bioavailability of its New Water Soluble Chemical Complex Coenzyme Q10-Beta Glucan 34
Other Significant Developments 36
Apr 23, 2018: Ceapro Provides Corporate Update – Company well poised to transition to its next phase of growth for expansion into the profitable nutraceutical sector 36
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
Ceapro Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Ceapro Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ceapro Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Ceapro Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ceapro Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Ceapro Inc, Medical Devices Deals, 2012 to YTD 2018 9
Ceapro Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Ceapro Enters into Agreement with Montreal Heart Institute 11
Ceapro Expands Licensing Agreement with University of Alberta 12
Symrise Enters Into Licensing Agreement With Ceapro 13
Ceapro Raises USD3.3 Million in Second and Final Tranche of Private Placement of Units 14
Ceapro Raises USD4.4 Million in First Tranche of Brokered Private Placement of Units 16
Ceapro Raises USD0.24 Million in Second Tranche of Private Placement of Debentures Due 2016 18
Ceapro Inc, Key Competitors 19
Ceapro Inc, Key Employees 20
Ceapro Inc, Subsidiaries 21

List of Figures
Ceapro Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Ceapro Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Ceapro Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Ceapro Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Ceapro Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ceapro Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Ceapro Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ceapro Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Ceapro Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Ceapro Inc (CZO):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • AUDI AG:企業の戦略・SWOT・財務情報
    AUDI AG - Strategy, SWOT and Corporate Finance Report Summary AUDI AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Excision BioTherapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Excision BioTherapeutics Inc (Excision BioTherapeutics) is a developer of gene editing therapeutics for the treatment of infectious diseases. The company’s products comprise EBT101, a HIV CRISPR Cas9 gRNA multiplex biologic for the prevention of Human Immunodeficiency Virus; EBT103, a PML JC …
  • Amazon.com, Inc.:戦略・SWOT・企業財務分析
    Amazon.com, Inc. - Strategy, SWOT and Corporate Finance Report Summary Amazon.com, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Saint-Gobain Weber GmbH:企業の戦略・SWOT・財務分析
    Saint-Gobain Weber GmbH - Strategy, SWOT and Corporate Finance Report Summary Saint-Gobain Weber GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Noevir Holdings Co Ltd (4928):企業の財務・戦略的SWOT分析
    Noevir Holdings Co Ltd (4928) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • ADESA Inc:企業の戦略的SWOT分析
    ADESA Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • National Fuel Gas Co (NFG):企業の財務・戦略的SWOT分析
    National Fuel Gas Co (NFG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • SimCorp AS (SIM):企業の財務・戦略的SWOT分析
    SimCorp AS (SIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Ingram Micro Inc.:企業の戦略・SWOT・財務情報
    Ingram Micro Inc. - Strategy, SWOT and Corporate Finance Report Summary Ingram Micro Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Bracco Imaging SpA:医療機器:M&Aディール及び事業提携情報
    Summary Bracco Imaging SpA (Bracco), a subsidiary of Bracco SpA, is a provider of diagnostic imaging solutions. The company offers diagnostic imaging, bracco pharma and health services. It offers solutions which include X-Ray, CT colonography, magnetic resonance imaging, diagnostic radiology, endosc …
  • B. Braun Melsungen AG:企業の戦略・SWOT・財務分析
    B. Braun Melsungen AG - Strategy, SWOT and Corporate Finance Report Summary B. Braun Melsungen AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • TransUnion LLC:企業のM&A・事業提携・投資動向
    TransUnion LLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's TransUnion LLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Corindus Vascular Robotics Inc (CVRS):医療機器:M&Aディール及び事業提携情報
    Summary Corindus Vascular Robotics Inc (Corindus) is a medical device company that designs, manufactures and commercializes remote robotic systems for interventional surgical procedures. The company offers next-generation CorPath GRX system, a robotic platform that enables improvements in procedural …
  • Castle Biosciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary Castle Biosciences Inc (Castle Biosciences) is a drug development company that develops and commercializes diagnostic and prognostic tests for cancers. The company offers tests for cutaneous melanoma, uveal melanoma and glioblastoma multiforme. Its DecisionDx-melanoma identifies stage I or I …
  • DCC Plc (DCC):石油・ガス:M&Aディール及び事業提携情報
    Summary DCC Plc (DCC) is a diversified company that offers international sales, marketing, distribution and business support services. The company operates through its business divisions such as LPG, retail, and oil, healthcare and technology. Its LPG business markets liquefied petroleum gas and nat …
  • Portland General Electric Co:企業の発電所・SWOT分析2018
    Portland General Electric Co - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Oberg Industries Inc:企業の戦略的SWOT分析
    Oberg Industries Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • PixCell Medical Technologies Ltd:企業の製品パイプライン分析
    Summary PixCell Medical Technologies Ltd (PixCell) is a medical device company that develops, produces and markets portable medical diagnostic products for point of care testing. The company’s product comprises hemoscreen, a portable hematology analyzer used for blood sampling and analysis. Its hemo …
  • One Call Care Management Inc-医療機器分野:企業M&A・提携分析
    Summary One Call Care Management Inc (OCCM), formerly One Call Medical Inc is a healthcare technology provider that offers specialized cost containment services. The company provides diagnostics, dental, transport, complex home care, equipment and physical therapy. It offers value added service and …
  • Barnwell Industries Inc Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Barnwell Industries Inc Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Barnwell Industries Inc (Barnwell) is a diversified company. The company's business activities include oil and natural gas, land investment, and contract drilling. Its oil and natural gas divisio …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆